Logo

Ocimum to Provide Microarray Analysis for Hospital of Joint Diseases

Jul 07, 2003

NEW YORK, July 7 - Bioinformatics startup Ocimum Biosolutions said today that it is collaborating with the Hospital of Joint Diseases at New York University's School of Medicine to analyze musculoskeletal disease data.

 

Ocimum will use its microarray analysis software Genowiz in the project.

 

Financial terms and other details of the project were not disclosed.

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.